Abbisko Therapeutics

company

About

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$28M
Industries
Health Care,Pharmaceutical,Therapeutics
Founded date
Apr 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$263M
Abbisko Therapeutics has raised a total of $263M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2021 Series D $123M 1 Detail
Mar 25, 2020 Series C $70M 1 Detail
Mar 21, 2019 Series B $42M 1 Detail
Feb 7, 2017 Series A $28M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Abbisko Therapeutics is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Series D